GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 42 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,207,000 | +29.4% | 524,664 | -3.3% | 0.35% | -10.5% |
Q1 2020 | $933,000 | -16.9% | 542,564 | 0.0% | 0.39% | +1.0% |
Q4 2019 | $1,123,000 | -28.6% | 542,564 | 0.0% | 0.38% | -35.0% |
Q3 2019 | $1,573,000 | -45.4% | 542,564 | -26.1% | 0.59% | -45.3% |
Q2 2019 | $2,879,000 | – | 734,422 | – | 1.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,765,901 | $4,273,000 | 2.32% |
NEA Management Company, LLC | 10,376,936 | $25,112,000 | 0.66% |
Polaris Venture Management Co. V, L.L.C. | 197,345 | $478,000 | 0.62% |
ABG Innovation Capital Partners III GP Ltd | 375,000 | $908,000 | 0.54% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,772,000 | 0.52% |
BVF INC/IL | 4,012,404 | $9,710,000 | 0.38% |
Avoro Capital Advisors LLC | 5,084,184 | $12,304,000 | 0.21% |
FNY Investment Advisers, LLC | 200,000 | $484,000 | 0.13% |
Boxer Capital, LLC | 1,134,453 | $2,745,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 130,745 | $316,000 | 0.05% |